Daily Stock Analysis, HBIO, Harvard Bioscience Inc, priceseries

Harvard Bioscience Inc. Daily Stock Analysis
Stock Information
Open
2.10
Close
2.10
High
2.16
Low
2.08
Previous Close
2.08
Daily Price Gain
0.02
YTD High
4.66
YTD High Date
Apr 12, 2019
YTD Low
1.92
YTD Low Date
Jun 12, 2019
YTD Price Change
-1.10
YTD Gain
-34.38%
52 Week High
6.70
52 Week High Date
Aug 15, 2018
52 Week Low
1.92
52 Week Low Date
Jun 12, 2019
52 Week Price Change
-2.93
52 Week Gain
-58.21%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 21. 2016
2.65
Jan 9. 2017
2.82
11 Trading Days
6.50%
Link
LONG
Jul 26. 2017
2.65
Aug 14. 2017
2.95
13 Trading Days
11.15%
Link
LONG
Apr 9. 2018
5.05
Apr 30. 2018
5.78
15 Trading Days
14.43%
Link
LONG
Jun 6. 2018
4.60
Jun 18. 2018
5.05
8 Trading Days
9.69%
Link
LONG
Jul 26. 2018
5.30
Aug 17. 2018
6.21
16 Trading Days
17.09%
Link
Company Information
Stock Symbol
HBIO
Exchange
NasdaqGM
Company URL
http://www.harvardbioscience.com
Company Phone
5088938999
CEO
Jeffrey A. Duchemin
Headquarters
Massachusetts
Business Address
84 OCTOBER HILL RD, HOLLISTON, MA 01746
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001123494
About

Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Description

Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company offers cell and animal physiology products, such as syringe pump and peristaltic pump products, as well as a range of instruments and accessories, including surgical products, infusion systems, microdialysis instruments, behavior research systems, and isolated organ and tissue bath systems, as well as in vivo and in vitro electrophysiology recording, stimulation, and analysis systems for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, Hugo-Sachs, InBreath Bioreactor, MCS, TBSI, and HEKA brands. It also provides products for molecular biology labs comprising pipettes and pipette tips, gloves, gel electrophoresis equipment and reagents, autoradiography films, thermal cycler accessories and reagents, sample preparation columns, tissue culture products, and general lab equipment and consumables under the Denville Scientific and other brands. In addition, the company offers spectrophotometers under the Libra, WPA, and BioDrop brands; microplate readers; amino acid analyzers; gel electrophoresis equipment under the Hoefer and Scie-Plas brands; and electroporation and electrofusion products, including systems and generators, electrodes, and accessories for research applications, such as in vivo, as well as in vitro gene delivery, cell fusion, and nuclear transfer cloning under the Harvard Apparatus BTX brand. Harvard Bioscience, Inc. markets its products to research scientists at universities, hospitals, government laboratories, and pharmaceutical and biotechnology companies. The company sells its products in approximately 100 countries through sales organization, Websites, catalogs, and distributors. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.